12-69353397-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000239.3(LYZ):​c.*178C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.87 in 670,562 control chromosomes in the GnomAD database, including 254,579 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.89 ( 60568 hom., cov: 32)
Exomes 𝑓: 0.86 ( 194011 hom. )

Consequence

LYZ
NM_000239.3 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.0560

Publications

11 publications found
Variant links:
Genes affected
LYZ (HGNC:6740): (lysozyme) This gene encodes human lysozyme, whose natural substrate is the bacterial cell wall peptidoglycan (cleaving the beta[1-4]glycosidic linkages between N-acetylmuramic acid and N-acetylglucosamine). Lysozyme is one of the antimicrobial agents found in human milk, and is also present in spleen, lung, kidney, white blood cells, plasma, saliva, and tears. The protein has antibacterial activity against a number of bacterial species. Missense mutations in this gene have been identified in heritable renal amyloidosis. [provided by RefSeq, Oct 2014]
LYZ Gene-Disease associations (from GenCC):
  • familial visceral amyloidosis
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • ALys amyloidosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 12-69353397-C-T is Benign according to our data. Variant chr12-69353397-C-T is described in ClinVar as Benign. ClinVar VariationId is 310335.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.96 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LYZNM_000239.3 linkc.*178C>T 3_prime_UTR_variant Exon 4 of 4 ENST00000261267.7 NP_000230.1 P61626B2R4C5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LYZENST00000261267.7 linkc.*178C>T 3_prime_UTR_variant Exon 4 of 4 1 NM_000239.3 ENSP00000261267.2 P61626
LYZENST00000549690.1 linkc.*132C>T 3_prime_UTR_variant Exon 3 of 3 2 ENSP00000449898.1 A0A0B4J259
ENSG00000257764ENST00000548900.1 linkn.*96G>A downstream_gene_variant 3

Frequencies

GnomAD3 genomes
AF:
0.890
AC:
135426
AN:
152122
Hom.:
60512
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.968
Gnomad AMI
AF:
0.897
Gnomad AMR
AF:
0.888
Gnomad ASJ
AF:
0.832
Gnomad EAS
AF:
0.929
Gnomad SAS
AF:
0.895
Gnomad FIN
AF:
0.833
Gnomad MID
AF:
0.737
Gnomad NFE
AF:
0.853
Gnomad OTH
AF:
0.859
GnomAD4 exome
AF:
0.864
AC:
447933
AN:
518324
Hom.:
194011
Cov.:
5
AF XY:
0.864
AC XY:
241315
AN XY:
279262
show subpopulations
African (AFR)
AF:
0.968
AC:
13766
AN:
14222
American (AMR)
AF:
0.903
AC:
25992
AN:
28770
Ashkenazi Jewish (ASJ)
AF:
0.834
AC:
14897
AN:
17864
East Asian (EAS)
AF:
0.926
AC:
29250
AN:
31578
South Asian (SAS)
AF:
0.887
AC:
49677
AN:
56012
European-Finnish (FIN)
AF:
0.830
AC:
28425
AN:
34260
Middle Eastern (MID)
AF:
0.767
AC:
2027
AN:
2642
European-Non Finnish (NFE)
AF:
0.851
AC:
258980
AN:
304146
Other (OTH)
AF:
0.864
AC:
24919
AN:
28830
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
2906
5813
8719
11626
14532
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1068
2136
3204
4272
5340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.890
AC:
135541
AN:
152238
Hom.:
60568
Cov.:
32
AF XY:
0.888
AC XY:
66096
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.968
AC:
40235
AN:
41556
American (AMR)
AF:
0.888
AC:
13576
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.832
AC:
2887
AN:
3470
East Asian (EAS)
AF:
0.929
AC:
4821
AN:
5188
South Asian (SAS)
AF:
0.894
AC:
4320
AN:
4832
European-Finnish (FIN)
AF:
0.833
AC:
8804
AN:
10574
Middle Eastern (MID)
AF:
0.738
AC:
217
AN:
294
European-Non Finnish (NFE)
AF:
0.853
AC:
58048
AN:
68012
Other (OTH)
AF:
0.859
AC:
1815
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
734
1468
2201
2935
3669
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
900
1800
2700
3600
4500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.866
Hom.:
184056
Bravo
AF:
0.896
Asia WGS
AF:
0.906
AC:
3151
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Familial visceral amyloidosis, Ostertag type Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
2.2
DANN
Benign
0.71
PhyloP100
0.056
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs710794; hg19: chr12-69747177; API